EDAP EDAP Medical: Aggregate Business Assets

EDAP TMS S.A. (EDAP) is a French leader in non-invasive prostate cancer treatment using HIFU. This chart illustrates total assets, which currently stand at 76.52. The uniqueness of its technologies grants the company significant pricing power over its systems. The business is currently focused on US expansion by growing its installed equipment base, although geopolitical risks and issues with Asian electronics may limit sales growth.

Global distribution of precision equipment by EDAP TMS S.A. and the optimization of supply chains ensure high margins, directly impacting the volume of controlled resources. By analyzing fluctuations in assets and resources calculated reverse-engineered through ROA, an investor assesses the aggregate of equity and liabilities, which allows for the verification of the business's fundamental resilience and justifies the long-term stability of market quotes.